AccelNet 6th Annual Meeting - Date 16-18 October Venue: Hilton Old Town Alexandria, Washington, USA

Letter by the COST Action officer

Following our collaboration and joint event organization with the NSF AccelNet Programme Challenges & solutions for data sharing in different research fields (cost.eu), the American partner informed us that they would be able to host participants from COST at their annual meeting. 

AccelNet 6th Annual Meeting is organized for the AccelNet Principal Investigators. The event is a great networking opportunity offering meeting and engaging with funded AccelNet project leaders and allowing to establish connections and start possible collaborations. The list of funded AccelNet projects can be browsed NSF Award Search: Advanced Search Results.  You can find the draft agenda enclosed for your information.

OHD Representative person Dr.Sheraz Gul (Fraunhofer, Hamburg, De)

Event details:

Date 16-18 October

Venue: Hilton Old Town Alexandria, Washington, USA 

Motivation

OneHealthdrugs (OHD) COST Action, wants to contribute to building of global pharmaceutical research and development consortia, training of research scientists, capacity building and refining data sharing protocols to ensure projects at different sites align seamlessly in relation to discovering lifesaving antiparasitic drugs with safe human profiles, animals and the environment. We at OHD aim to achieve this by adopting a multidisciplinary platform to approach the problem.

Attending the AccelNet 6th Annual Meeting will be an ideal opportunity to meet experts in their respective fields of research, to both learn and share our experiences in relation to international networking. The presentations listed in the agenda will provide insights into the different approaches being undertaken to build productive consortia in the field of pharmaceutical research. The event will provide a unique platform to gain fresh insights and stay updated on the latest trends and innovations in networking. Engaging with like-minded individuals, participating in thought-provoking discussions, and hearing from experts will provide new ideas on how our Action can implement new projects in the future.

Beyond the content, attending the event demonstrates our commitment to lifelong learning and professional development, as a valuable experience and empower us create a lasting impact on our future projects.

Abstract

As a OneHealdrugs participants, We are motivated to bring the essence of our action around the different initiatives in the world, to collect interest and to contaminate with the action objective: To provide life-saving antiparasitic drugs with a safer profile for humans, animals and the environment. We adopt a multidisciplinary platform to approach the problem that has a huge under considered dimension.

The concrete objective to participate to the events AccelNet 6th Annual Meeting are: ì) to introduce the concepts/tools of early design of safer drugs to the stakeholders working in the pharmaceutical field; ii) to include in the drug discovery process a panel of assays allowing the evaluation of the effect on environmental models; iii) to focus on veterinary drugs and to interact with interested pharmaceutical companies for collaboration in this field.

We are developing a suitable tool for early evaluation of the ecotoxicological profile of compounds/expected drug candidates; a platform with a database for training and evaluation of a few thousand known compounds and a forthcoming toolbox with unpublished/published compounds for experimental testing: applicable models for ecotoxicological evaluation of compounds in the discovery phase to promote the selection of the best compounds.  Collaboration in this area would be highly relevant.

We are also writing guidelines for the integration of advanced greener concepts in the antiparasitic drugs discovery pipeline.